RedHill Biopharma Announces Pricing of $20 Million Underwritten Offering
TEL-AVIV, Israel and RALEIGH, N.C., Dec. 06, 2018 (GLOBE NEWSWIRE) — RedHill Biopharma Ltd. (Nasdaq:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or […]
Arena Minerals Acquires Antofalla Minerals
TORONTO, Dec. 06, 2018 (GLOBE NEWSWIRE) — Arena Minerals Inc. (“Arena” or the “Company”) (TSX-V: AN) is pleased to confirm […]
FONAR Founder Raymond V. Damadian, M.D., Receives Medal of Honor for the Discovery and Invention of MRI, From the Chiari & Syringomyelia Foundation
MELVILLE, N.Y., Dec. 06, 2018 (GLOBE NEWSWIRE) — FONAR Corporation (NASDAQ-FONR), Inventor of MR Scanning™, reported that its founder, chairman […]
Marrone Bio Innovations Launches TerraConnect™ New Biological Seed and Soil Platform
DAVIS, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), launches TerraConnect, a new global […]
Edison Nation Announces Global Distribution Agreement for Everyday Edisons TV Series
Expanded Distribution to Further Develop the Edison Nation Brand within Global Inventor Marketplace PHILLIPSBURG, N.J., Dec. 06, 2018 (GLOBE NEWSWIRE) […]
Glance Technologies Provides Small Businesses With Access To Funding Through New Partnership With Merchant Advance Capital
VANCOUVER, British Columbia, Dec. 06, 2018 (GLOBE NEWSWIRE) — Glance Technologies Inc. (“Glance” or the “Company”) (CSE:GET.CN) (OTCQB:GLNNF) (FKT:GJT) today […]
Ultragenyx and Kyowa Kirin Announce Health Canada Approval of Crysvita™ (burosumab injection) for the Treatment of X–linked Hypophosphatemia (XLH) in Adults and Children
First Approved Treatment for XLH in Canada that Targets the Underlying Cause of this Rare, Hereditary, Lifelong Disease NOVATO, Calif., […]
SELLAS Life Sciences Announces Additional Positive Triple Negative Breast Cancer (TNBC) Subgroup Data from Phase 2b Study of Nelipepimut-S Plus Trastuzumab at the 2018 San Antonio Breast Cancer Symposium
Clinically Meaningful and Statistically Significant Decrease in the Frequency of Clinically Detected Recurrences in the TNBC Cohort Treated with Nelipepimut-S […]
Veru to Report Fiscal Year 2018 Financial Results, Host Conference Call on December 13th
MIAMI, Dec. 06, 2018 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, today announced that […]
ADDvantage Technologies Group, Inc. to Report Financial Results For the Fiscal Fourth Quarter of 2018
BROKEN ARROW, Okla., Dec. 06, 2018 (GLOBE NEWSWIRE) — ADDvantage Technologies Group, Inc. (NASDAQ: AEY) announced today that it will […]
